Part II. Reportable Neoplasms

The essential criteria for a reportable tumor is a diagnosis of cancer by a physician, surgeon, or dentist, even if it is not pathologically confirmed.

Chapter II Contents

II.1		Determining Reportability
II.1.1		Criterion for Reportability of Benign/Borderline Brain and CNS Tumors
II.1.2		Identifying the Primary Neoplasm
II.1.2.1		Metastasis
II.1.2.2		Abstracting Each Primary
II.1.3		Single and Multiple Primaries
II.1.3.1		Single Primaries
II.1.3.2		Multiple Primaries
II.1.3.3		Paired Sites
II.1.3.4		Breast Ductal and Lobular Carcinomas
II.1.3.5		Intraductal Carcinoma and Paget Disease
II.1.3.6		Lymphatic and Hematopoietic Diseases - Subsequent
II.1.3.7		Single and Multiple Primaries, Kaposi's Sarcoma
II.1.4		Skin Carcinomas
II.1.4.1		Skin Carcinoma Exceptions
II.1.4.2		Reportable Skin Tumors
II.1.5		Cervix
II.1.6		Ambiguous Diagnostic Terms
II.1.6.1		Reportable Terms
II.1.6.2		Non-Reportable Terms
II.1.6.3		Negative Biopsies
II.1.7		Pathology, Tumor Board, and Consultation Only
II.1.8		Hematopoietic and Lymphoid Neoplasm
II.1.9		Benign/Borderline Intracranial and CNS Tumors
II.1.9.1		Reportability - Benign/Borderline Brain and CNS Tumors
II.1.9.2		Determining Multiple Primaries For Brain and CNS Tumors
II.1.9.3		Date of Diagnosis For Brain and CNS Tumors
II.1.9.4		Sequence Number For Brain and CNS Tumors
II.1.9.5		Malignant Transformation - Brain and CNS Tumors
II.1.9.6		Tumor Grade - Benign/Borderline Brain and CNS Tumors
II.1.9.7		WHO Grade - Benign/Borderline Brain and CNS Tumors
II.1.9.8		CS Staging - Benign/Borderlione Brain and CNS Tumors
II.1.10		Borderline Ovarian Tumors
II.2		Abstracting Preliminary Procedures
II.2.1		Year First Seen
II.2.3		Accession Number
II.2.4		Sequence Number
II.2.4.1		Simultaneous Diagnosis
II.2.4.2		Updating the Sequence Number
II.2.5		Other Tumors

<< Prev. Next >>